CNS Pharmaceuticals, Inc. (CNSP) financial statements and ratios from SEC XBRL: revenue $27687.00 (TTM), net margin -68086.9%. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $27687.00 |
| Net Margin | -68086.9% |
| Price / Book | 0.47 |
| FCF Yield | -204.3% |
| Sector P/E (Healthcare) | 21.7 |
CNSP overview · CNSP earnings · CNSP KPIs · CNSP investor relations · CNSP ownership · CNSP peers · CNSP filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.